QuantiFERON-TB Gold and selected region of difference 1 peptide-based assays for the detection of Mycobacterium tuberculosis infection in a cohort of patients enrolled with suspected tuberculosis

Diagnostic Microbiology and Infectious Disease

Volumn 62, Issue 4, 2008, Pages 395-401

  Sauzullo, Ilaria ^a   Mengoni, Fabio ^a   Lichtner, Miriam ^a   Rossi, Raffaella ^a   Massetti, Anna P ^a   Mastroianni, Claudio M ^a   Vullo, Vincenzo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

IFN Assay; Peptides; QuantiFERON TB Gold; Tuberculosis

Indexed keywords

CULTURE FILTRATE PROTEIN 10; GAMMA INTERFERON; GOLD; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; BACTERIUM DETECTION; CLINICAL PRACTICE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNE RESPONSE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PATIENT SELECTION; PRIORITY JOURNAL; PROTEIN TARGETING; TUBERCULIN TEST; TUBERCULOSIS;

ADOLESCENT; ADULT; FEMALE; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; TUBERCULOSIS;

EID: 56249086054     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2008.08.015     Document Type: Article

References (33)

1. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am. J. Respir. Crit. Care Med. 161 (2000) S221-S247
2. Andersen P., Munk M.E., Pollock J.M., and Doherty T.M. Specific immune-based diagnosis of tuberculosis. Lancet 356 (2000) 1099-1104
3. Barnes P.F. Diagnosing latent tuberculosis infection: turning glitter to gold. Am. J. Respir. Crit. Care Med. 170 (2004) 5-6
4. Behr M.A., Wilson M.A., Gill W.P., Salamon H., Schoolnik G.K., Rane S., and Small P.M. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 284 (1999) 1520-1523
5. Berthet F.X., Rasmussen P.B., Rosenkrands I., Andersen P., and Gicquel B. A Mycobacterium tuberculosis operon encoding ESAT-6 and a novel low-molecular-mass culture filtrate protein (CFP-10). Microbiology 144 (1998) 3195-3203
6. Bossuyt P.M., Reitsma J.B., Bruns D.E., Gatsonis C.A., Glasziou P.P., Irwig L.M., Lijmer J.G., Moher D., Rennie D., and de Vet H.C. Standards for reporting of diagnostic accuracy. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Croat Med. J. 44 (2003) 639-650
7. Brock I., Ruhwald M., Lundgren B., Westh H., Mathiesen L.R., and Ravn P. Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon gamma test. Respir. Res. 1 (2006) 7-56
8. Broekmans J.F., Migliori G.B., Rieder H.L., Lees J., Ruutu P., Loddenkemper R., and Raviglione M.C. European framework for tuberculosis control and elimination in countries with a low incidence. Recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculosis Association (KNCV) Working Group. Eur. Respir. J. 19 (2002) 765-775
9. Carrara S., Vincenti D., Petrosillo N., Amicosante M., Girardi E., and Goletti D. Use of a T-cell-based assay for monitoring efficacy of antituberculosis therapy. Clin. Infect. Dis. 38 (2004) 754-756
10. Chapman A.L., Munkanta M., Wilkinson K.A., Pathan A.A., Ewer K., Ayles H., Reece W.H., Mwinga A., Godfrey-Faussett P., and Lalvani A. Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells. AIDS 16 (2002) 2285-2293
11. Dheda K., Lalvani A., Miller R.F., Scott G., Booth H., Johnson M.A., and Rook G.A. Performance of a T-cell-based diagnostic test for tuberculosis infection in HIV-infected individuals is independent of CD4 cell count. AIDS 19 (2005) 2038-2041
12. Dye C., Scheele S., Dolin P., Pathania V., and Raviglione M.C. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. Who global surveillance and monitoring project. JAMA 282 (1999) 677-686
13. Ferebee S.H. Controlled chemoprophylaxis trials in tuberculosis. A general review. Bibl. Tuberc. 26 (1970) 28-106
14. Goletti D., Vincenti D., Carrara S., Butera O., Bizzoni F., Bernardini G., Amicosante M., and Girardi E. Selected RD1 peptides for active tuberculosis diagnosis: comparison of a gamma interferon whole-blood enzyme-linked immunosorbent assay and an enzyme-linked immunospot assay. Clin. Diagn. Lab. Immunol. 12 (2005) 1311-1316
15. Goletti D., Butera O., Bizzoni F., Casetti R., Girardi E., and Poccia F. Region of difference 1 antigen-specific CD4+ memory T cells correlate with a favourable outcome of tuberculosis. J. Infect. Dis. 194 (2006) 984-992
16. Goletti D., Carrara S., Vincenti D., Saltini C., Busi Rizzi E., Schininà V., Ippolito G., Amicosante M., and Girardi E. Accuracy of an immune diagnostic assay based on RD1 selected epitome for active tuberculosis in a clinical setting: a pilot study. Clin. Microbiol. Infect. 12 (2006) 544-550
17. Huebner R.E., Schein M.F., and Bass J.B. The tuberculin skin test. Clin. Infect. Dis. 17 (1993) 968-975
18. Jasmer R.M., Nahid P., and Hopewell P.C. Latent tuberculosis infection. N. Engl. J. Med. 347 (2002) 1860-1866
19. Lalvani A. Spotting latent infection: the part to better tuberculosis control. Thorax 58 (2003) 916-918
20. Lalvani A., Nagvenkar P., Udwadia Z., Pathan A.A., Wilkinson K.A., Shastri J.S., Ewer K., Hill A.V., Mehta A., and Rodrigues C. Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians. J. Infect. Dis. 183 (2001) 469-477
21. Lin Y., Zhang M., Hofman F.M., Gong J., and Barnes P.F. Absence of a prominent Th2 cytokine response in human tuberculosis. Infect. Immun. 64 (1996) 1351-1356
22. Mazurek G.H., and Villarino M.E. Guidelines for using the QuantiFERON-TB test for diagnosing latent M. tuberculosis infection. Center for Disease Control and Prevention. MMWR Recomm. Rep. 52 (2003) 15-18
23. Mazurek G.H., Jereb J., Lobue P., Iademarco M.F., Metchock B., and Vernon A. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR. Recomm. Rep. 54 (2005) 49-55
24. Menzies D., Pai M., and Comstock G. Meta-analysis for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann. Intern. Med. 146 (2007) 340-354
25. Nicol M.P., Pienaar D., Wood K., Eley B., Wilkinson R.J., Henderson H., Smith L., Samodien S., and Beatty D. Enzyme-linked immunospot assay responses to early secretory antigenic target 6, culture filtrate protein 10, and purified protein derivative among children with tuberculosis: implications for diagnosis and monitoring of therapy. Clin. Infect. Dis. 40 (2005) 1301-1308
26. Nicol M.P., Sola C., February B., Rastogi N., Steyn L., and Wilkinson R.J. Distribution of strain families of Mycobacterium tuberculosis causing pulmonary and extrapulmonary disease in hospitalized children in Cape Town, South Africa. J. Clin. Microbiol. 43 (2005) 5779-5781
27. Pai M., Riley L.W., and Colford J.M. Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systemic review. Lancet Infect. Dis. 4 (2004) 761-776
28. Pathan A.A., Wilkinson K.A., Klenerman P., McShane H., Davidson R.N., Pasvol G., Hill A.V., and Lalvani A. Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment. J. Immunol. 167 (2001) 5217-5225
29. Sturniolo T., Bono E., Ding J., Raddrizzani L., Tuereci O., Sahin U., Braxenthaler M., Gallazzi F., Protti M.P., Sinigaglia F., and Hammer J. Generation of tissue-specific and promiscuous HLA ligand database using DNA microarrays and virtual HLA class II matrices. Nat. Biotechnol. 17 (1999) 555-561
30. United States Food and Drug Administrations (accessed 14 April 2005). Approval for the use of synthetic peptide antigens used in the QuantiFERON-TB Gold. [http://www.fda.gov/cdrh/pma/pmadec04.html].
31. Vincenti D., Carrara S., De Mori P., Pupillo L.P., Petrosillo N., Palmieri F., Armignacco O., Ippolito G., Girardi E., Amicosante M., and Goletti D. Identification of ESAT-6 epitopes for the immunodiagnosis of active tuberculosis. Mol. Med. 19 (2003) 105-111
32. Whalen C.C., Johnson J.L., Okwera A., Hom D.L., Huebner R., Mugyenvi P., Mugerrwa R.D., and Ellner J.J. A trial of three regimens to prevent tuberculosis in Uganda adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration. N. Engl. J. Med. 337 (1997) 801-808
33. Zhang M., Lin Y., Iyer D.V., Gong J., Abrams J.S., and Barnes P.F. T cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect. Immun. 63 (1995) 3231-3234